A Multi-site Study of Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy
Clinical trial NCT02612155 · COMPLETED
Trial details
- NCT number
- NCT02612155
- Sponsor
- Michael Cotten
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2019-08-05
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.